Aspectos Clínicos y Epidemiológicos del VIH y Condiciones Asociadas

Jimenez-Sousa, MA; Berenguer, J; Garcia-Alvarez, M; Gutierrez-Rivas, M; Aldamiz-Echevarria, T; Tejerina, F; Diez, C; Vazquez-Moron, S; Resino, S.

Impact of patatin-like phospholipase domain-containing 3 gene polymorphism (rs738409) on severity of liver disease in HIV/hepatitis C virus-coinfected patients

AIDS. 2016; 30(3): 465-470 Nº de citas: 13 [doi:10.1097/QAD.0000000000000908]

Perez-Latorre, L; Rivero-Juarez, A; Hontanon, V; Diez, C; Cuenca, F; Martin-Carbonero, ML; Montes, ML; Bellon, JM; Aldamiz-Echevarria, T; Carrero, A; Rivero, A; Gonzalez-Garcia, J; Berenguer, J.

Prognostic Value of Transient Elastography in Human Immunodeficiency Virus-Infected Patients With Chronic Hepatitis C

Open Forum Infectious Diseases. 2016; 3(4): Nº de citas: 8 [doi:10.1093/ofid/ofw212]

Berenguer, J; Rivero, A; Jarrin, I; Nunez, MJ; Vivancos, MJ; Crespo, M; Tellez, MJ; Domingo, P; Iribarren, JA; Artero, A; Marquez, M; Santos, I; Moreno, J; Montero, M; Gonzalez-Garcia, J.

Human Immunodeficiency Virus/Hepatitis C Virus Coinfection in Spain: Prevalence and Patient Characteristics

Open Forum Infectious Diseases. 2016; 3(2): Nº de citas: 32 [doi:10.1093/ofid/ofw059]

Serrano-Villar, S; Gutierrez, F; Miralles, C; Berenguer, J; Rivero, A; Martinez, E; Moreno, S.

Human Immunodeficiency Virus as a Chronic Disease: Evaluation and Management of Nonacquired Immune Deficiency Syndrome-Defining Conditions

Open Forum Infectious Diseases. 2016; 3(2): Nº de citas: 37 [doi:10.1093/ofid/ofw097]

Walmsley, S; Baumgarten, A; Berenguer, J; Felizarta, F; Florence, E; Khuong-Josses, MA; Kilby, JM; Lutz, T; Podzamczer, D; Portilla, J; Roth, N; Wong, D; Granier, C; Wynne, B; Pappa, K.

Dolutegravir Plus Abacavir/Lamivudine for the Treatment of HIV-1 Infection in Antiretroviral Therapy-Naive Patients: Week 96 and Week 144 Results From the SINGLE Randomized Clinical Trial

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES. 2015; 70(5): 515-519 Nº de citas: 191 [doi:10.1097/QAI.0000000000000790]

Fernandez-Rodriguez, A; Berenguer, J; Jimenez-Sousa, MA; Garcia-Alvarez, M; Aldamiz-Echevarria, T; Pineda-Tenor, D; Diez, C; de la Barrera, J; Bellon, JM; Briz, V; Resino, S.

Toll-like receptor 8 (TLR8) polymorphisms are associated with non-progression of chronic hepatitis C in HIV/HCV coinfected patients

INFECTION GENETICS AND EVOLUTION. 2015; 36: 339-344 Nº de citas: 8 [doi:10.1016/j.meegid.2015.10.006]

Gomez, CE; Perdiguero, B; Garcia-Arriaza, J; Cepeda, V; Sanchez-Sorzano, CO; Mothe, B; Jimenez, JL; Munoz-Fernandez, MA; Gatell, JM; de Quiros, JCLB; Brander, C; Garcia, F; Esteban, M.

A Phase I Randomized Therapeutic MVA-B Vaccination Improves the Magnitude and Quality of the T Cell Immune Responses in HIV-1-Infected Subjects on HAART

PLoS One. 2015; 10(11): Nº de citas: 20 [doi:10.1371/journal.pone.0141456]

Santos, JR; Blanco, JL; Masia, M; Gutierrez, F; Perez-Elias, MJ; Iribarren, JA; Force, L; Antela, A; Knobel, H; Salavert, M; De Quiros, JCLB; Pino, M; Paredes, R; Clotet, B.

Virological failure to raltegravir in Spain: incidence, prevalence and clinical consequences

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2015; 70(11): 3087-3095 Nº de citas: 12 [doi:10.1093/jac/dkv205]

Guzman-Fulgencio, M; Berenguer, J; Jimenez-Sousa, MA; Micheloud, D; Garcia-Alvarez, M; Bellon, JM; Aldamiz-Echevarria, T; Garcia-Broncano, P; Catalan, P; Diez, C; Pineda-Tenor, D; Resino, S.

IL7RA polymorphisms predict the CD4+recovery in HIV patients on cART

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2015; 45(11): 1192-1199 Nº de citas: 16 [doi:10.1111/eci.12539]

Berenguer, J; Polo, R; Aldeguer, JL; Lozano, F; Aguirrebengoa, K; Arribas, JR; Blanco, JR; Boix, V; Casado, JL; Clotet, B; Crespo, M; Domingo, P; Estrada, V; Garcia, F; Gatell, JM; Gonzalez-Garcia, J; Gutierrez, F; Iribarren, JA; Knobel, H; Llibre, JM; Locutura, J; Lopez, JC; Miro, JM; Moreno, S; Podzamczer, D; Portilla, J; Pulido, F; Ribera, E; Riera, M; Rubio, R; Santos, J; Sanz-Moreno, J; Sanz, J; Tellez, MJ; Tuset, M; Rivero, A.

Executive summary of the GESIDA/National AIDS Plan Consensus Document on antiretroviral therapy in adults infected by the human immunodeficiency virus (updated January 2015)

ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA. 2015; 33(8): 544-556 Nº de citas: 9 [doi:10.1016/j.eimc.2015.03.017]

Soriano, V; Berenguer, J.

Extrahepatic comorbidities associated with hepatitis C virus in HIV-infected patients

Current Opinion in HIV and AIDS. 2015; 10(5): 309-315 Nº de citas: 25 [doi:10.1097/COH.0000000000000175]

Mills, A; Garner, W; Pozniak, A; Berenguer, J; Speck, R; Bender, R; Thai, N.

Patient-Reported Symptoms Over 48 Weeks in a Randomized, Open-Label, Phase IIIb Non-Inferiority Trial of Adults with HIV Switching to Co-Formulated Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir DF versus Continuation of Non-Nucleoside Reverse Transcriptase Inhibitor with Emtricitabine and Tenofovir DF

Patient-Patient Centered Outcomes Research. 2015; 8(4): 359-371 Nº de citas: 14 [doi:10.1007/s40271-015-0129-9]

Aldamiz-Echevarria, T; Gonzalez-Garcia, J; Von Wichmann, MA; Crespo, M; Lopez-Aldeguer, J; Quereda, C; Tellez, MJ; Galindo, MJ; Sanz, J; Santos, I; Guardiola, JM; Bellon, JM; Montes, M; Berenguer, J.

Association of baseline CD4+cell count and HIV-RNA on sustained virologic response to interferon-ribavirin in HIV/HCV coinfected patients

Annals of Hepatology. 2015; 14(4): 464-469 Nº de citas: 3 [doi:10.1016/S1665-2681(19)31167-6]

Martinez, E; Ribera, E; Clotet, B; Estrada, V; Sanz, J; Berenguer, J; Rubio, R; Pulido, F; Larrousse, M; Curran, A; Negredo, E; Arterburn, S; Ferrer, P; Alvarez, ML.

Switching from zidovudine/lamivudine to tenofovir/emtricitabine improves fat distribution as measured by fat mass ratio

HIV MEDICINE. 2015; 16(6): 370-374 Nº de citas: 4 [doi:10.1111/hiv.12210]

Guzman-Fulgencio, M; Berenguer, J; Jimenez-Sousa, MA; Pineda-Tenor, D; Aldamiz-Echevarria, T; Garcia-Broncano, P; Carrero, A; Garcia-Alvarez, M; Tejerina, F; Diez, C; Vazquez-Moron, S; Resino, S.

Association between IL7R polymorphisms and severe liver disease in HIV/HCV coinfected patients: a cross-sectional study

Journal of Translational Medicine. 2015; 13: Nº de citas: 12 [doi:10.1186/s12967-015-0577-y]

Mothe, B; Climent, N; Plana, M; Rosas, M; Jimenez, JL; Munoz-Fernandez, MA; Puertas, MC; Carrillo, J; Gonzalez, N; Leon, A; Pich, J; Arnaiz, JA; Gatell, JM; Clotet, B; Blanco, J; Alcami, J; Martinez-Picado, J; Alvarez-Fernandez, C; Sanchez-Palomino, S; Guardo, AC; Pena, J; Benito, JM; Rallon, N; Gomez, CE; Perdiguero, B; Garcia-Arriaza, J; Esteban, M; de Quiros, JCLB; Brander, C; Garcia, F.

Safety and immunogenicity of a modified vaccinia Ankara-based HIV-1 vaccine (MVA-B) in HIV-1-infected patients alone or in combination with a drug to reactivate latent HIV-1

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2015; 70(6): 1833-1842 Nº de citas: 56 [doi:10.1093/jac/dkv046]

Pacheco, YM; Jarrin, I; Rosado, I; Campins, AA; Berenguer, J; Iribarren, JA; Rivero, M; Munoz-Medina, L; Bernal-Morell, E; Gutierrez, F; Leal, M.

Increased risk of non-AIDS-related events in HIV subjects with persistent low CD4 counts despite cART in the CoRIS cohort

ANTIVIRAL RESEARCH. 2015; 117: 69-74 Nº de citas: 84 [doi:10.1016/j.antiviral.2015.03.002]

Baptista, MJ; Garcia, O; Morgades, M; Gonzalez-Barca, E; Miralles, P; Lopez-Guillermo, A; Abella, E; Moreno, M; Sancho, JM; Feliu, E; Ribera, JM; Navarro, JT.

HIV-infection impact on clinical-biological features and outcome of diffuse large B-cell lymphoma treated with R-CHOP in the combination antiretroviral therapy era

AIDS. 2015; 29(7): 811-818 Nº de citas: 38 [doi:10.1097/QAD.0000000000000624]